Because of our additional prior studies showing that hypothalamic BDNF mediates the improved metabolism and cancer outcomes in previous obesity and cancer EE studies, we hypothesized that TrkB signaling was also responsible for the outcomes we saw in the BTBR EE study. The gene discussed is NTRK2; the disease is obesity due to melanocortin 4 receptor deficiency.